Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma

被引:75
|
作者
Demirag, F
Ünsal, E
Yilmaz, A
Çaglar, A
机构
[1] Ataturk Chest Dis & Chest Surg Educ & Res Hosp, Dept Pathol, Ankara, Turkey
[2] Ataturk Chest Dis & Chest Surg Educ & Res Hosp, Dept Chest Dis, Ankara, Turkey
[3] Kafkas Univ, Sci & Art Fac, Dept Stat, Kars, Turkey
关键词
malignant mesothelioma; mitosis; prognosis; tumor necrosis; vascular endothelial growth factor;
D O I
10.1378/chest.128.5.3382
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Tumor growth and metastasis are angiogenesis-dependent events, and several prognostic factors have been determined in malignant mesothelioma. In this study, we investigated the prognostic significance of vascular endothelial growth factor (VEGF), tumor necrosis (TN), and mitotic activity index (MAI) in malignant mesothelioma. For the first time (to our knowledge), we also demonstrated the association between VEGF staining, TN, and MAI in malignant mesothelioma. Methods: Decortication and VATS materials of 40 patients were investigated. The routinely processed formalin-fixed, paraffin-embedded, hematoxylin-eosin-stained tumor sections that had been used for the original diagnostic purposes were retrieved. Hematoxylin-eosin sections were selected for VEGF immunostaining, TN, and mitotic count. Clinicopathologic data, stage of disease, and survival of patients were all determined. The correlations between variables were evaluated by Spearman rank correlation test. Both univariate analysis using the log-rank test and multivariate analysis using Cox regression model were performed for survival analysis. Results: There was a significant correlation between VEGF staining and TIN (r = 0.42, p = 0.006). In univariate analysis, both VEGF staining (p = 0.0002) and TN (p = 0.0055) showed significant correlation with short survival. Also, there was a positive correlation between VEGF and tumor stage (p = 0.046). In multivariate analysis, only VEGF was determined as an independent prognostic factor in malignant mesothelioma (p = 0.001). There was no association between MAI and survival (p = 0.504). Conclusions: VEGF, known as an important angiogenic peptide, is an independent prognostic factor in malignant pleural mesothelioma. TN stimulates angiogenesis, and we observed a significant correlation between VEGF and TN. However, further studies are needed to evaluate the prognostic significance of angiogenic properties in malignant mesothelioma.
引用
收藏
页码:3382 / 3387
页数:6
相关论文
共 50 条
  • [1] Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma
    Fujimoto, Nobukazu
    Gemba, Kenichi
    Kishimoto, Takumi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (05) : 971 - 972
  • [2] Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma
    Yasumitsu, Akihiro
    Tabata, Chiharu
    Tabata, Rie
    Hirayama, Noriko
    Murakami, Aki
    Yamada, Shusai
    Terada, Takayuki
    Iida, Shinichiro
    Tamura, Kunihiro
    Fukuoka, Kazuya
    Kuribayashi, Kozo
    Nakano, Takashi
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (04) : 479 - 483
  • [3] Expression of vascular endothelial growth factor in diffuse malignant pleural mesothelioma
    König, JE
    Tolnay, E
    Wiethege, T
    Müller, KM
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 435 (01): : 8 - 12
  • [4] Expression of vascular endothelial growth factor in diffuse malignant pleural mesothelioma
    Jens-Ekkehard König
    Edina Tolnay
    Thorsten Wiethege
    K.-M. Müller
    Virchows Archiv, 1999, 435 : 8 - 12
  • [5] Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma
    Krasinskas, Alyssa M.
    Borczuk, Alain C.
    Hartman, Douglas J.
    Chabot, John A.
    Taub, Robert N.
    Mogal, Ashish
    Pingpank, James
    Bartlett, David
    Dacic, Sanja
    HISTOPATHOLOGY, 2016, 68 (05) : 729 - 737
  • [6] Expression of vascular endothelial growth factor in malignant mesothelioma
    Aoe, Keisuke
    Hiraki, Akio
    Tanaka, Takehiro
    Gemba, Ken-Ichi
    Taguchi, Koji
    Murakami, Tomoyuki
    Sueoka, Naoko
    Kamei, Toshiaki
    Ueoka, Hiroshi
    Sugi, Kazuro
    Yoshino, Tadashi
    Kishimoto, Takumi
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4833 - 4836
  • [7] COMPARISON OF POTENTIAL VALUES OF HYALURONIC ACID AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN THE PLEURAL FLUID OF MALIGNANT PLEURAL MESOTHELIOMA
    Fujimoto, Nobukazu
    Gemba, Kenichi
    Asano, Michiko
    Wada, Sae
    Ono, Katsuichiro
    Ozaki, Shinji
    Kishimoto, Takumi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S921 - S922
  • [8] Is Laboratory Prognostic Index a Valuable Prognostic Index for Malignant Pleural Mesothelioma?
    Tuylu, T. Basoglu
    Demircan, N. C.
    Arikan, R.
    Telli, T. Akin
    Alan, O.
    Ercelep, O.
    Bozkurtlar, E.
    Kocakaya, D.
    Kaya, S.
    Babacan, N.
    Lacin, T.
    Dane, F.
    Ahiskali, R.
    Batirel, H.
    Yumuk, P. F.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S763 - S763
  • [9] Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
    Strizzi, L
    Catalano, A
    Vianale, G
    Orecchia, S
    Casalini, A
    Tassi, G
    Puntoni, R
    Mutti, L
    Procopio, A
    JOURNAL OF PATHOLOGY, 2001, 193 (04): : 468 - 475
  • [10] Role of viral induced vascular endothelial growth factor (VEGF) production in pleural effusion and malignant mesothelioma
    Woernle, Markus
    Sauter, Matthias
    Kastenmueller, Kathrin
    Ribeiro, Andrea
    Roeder, Maximilian
    Mussack, Thomas
    Ladurner, Roland
    Sitter, Thomas
    CELL BIOLOGY INTERNATIONAL, 2009, 33 (02) : 180 - 186